Loading...
Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
Cetuximab is a monoclonal antibody able to inhibit and to degrade the transmembrane receptor Her-1, also known as epidermal growth factor receptor (EGFR). The inhibition of EGFR is of major importance since the receptor influences many important tumor cell activities including tumor growth, neo-angi...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2007
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376084/ https://ncbi.nlm.nih.gov/pubmed/18473010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|